Navigation Links
Auditors for Genta Incorporated Express Going Concern Qualification

/" target="_new">

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward-looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory approval for

Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or product


-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

-- the Company's ability to enter into and successfully execute license

and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing

to maintain the Company's planned operations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such


-- the Company's ability to retain compliance with the NASDAQ's listing

qualifications; and

-- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that cou

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genta Announces Senior Management Changes
2. Genta Announces Common Stock Offering of Approximately $3.1 Million
3. Genta Incorporated to Present at the BIO CEO & Investor Conference
4. Genta Receives Notice of Non-Compliance With NASDAQ Rule
5. Genta Receives NASDAQ Non-Compliance Notice
6. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
7. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
8. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
9. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
10. Syngenta Licenses Chromatin Gene Stacking Technology
11. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  Sorrento Therapeutics, Inc. ... new treatments for cancer and associated pain, announced today ... will be presenting at the Aegis Capital Corporation ... :Event:Aegis Capital Corporation 2015 Growth ConferenceDate:Friday, October ... The Encore @ The Wynn in Las Vegas, ...
(Date:10/8/2015)... Maryland , October 8, 2015 ... .   --> Goldman Small ... in the small cap and microcap sectors, announced ... research report on PharmaCyte Biotech, Inc. (OTCQB - ... focused on developing and preparing treatments for cancer ...
(Date:10/8/2015)... 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, today announced its ... taking place in the month of October: ... RepliCel will be presenting at the annual Partnering ... Mesa to be held October 7-9 in ...
(Date:10/8/2015)... ... October 08, 2015 , ... ... fibrosis transmembrane conductance regulator (CFTR) gene and results in dysfunction of the lungs ... accumulates in the lungs. This mucus is very difficult to clear, blocks the ...
Breaking Biology Technology:
... Mass. and SYDNEY, Sept. 14, 2011 HeartWare International, ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that CEO Doug Godshall is scheduled ... at 10:30 a.m. ET on Wednesday, September 21, 2011. ...
... Sept. 14, 2011 Tengion, Inc. (NASDAQ: TNGN ... Davis, Vice President Finance and Chief Financial Officer of Tengion, ... on Monday, September 19, 2011, at 1:30 pm EDT. ... accessed under "Calendar of Events" in the Investors section of ...
... 13Researchers at Vanderbilt University have developed a new technique that ... tissue at multiple points simultaneously, a method that could help ... and change shape. UV lasers are a commonly-used ... incisions by vaporizing one point at a time in a ...
Cached Biology Technology:
(Date:10/8/2015)... 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet announces that revenues for the three months ... with $113,00 for the three months ended June ... September 30, 2015 were approximately $520,000. ...
(Date:10/6/2015)... 6, 2015  Maverix Biomics, Inc., a leading ... its software portfolio with the debut of its ... expression in eukaryotes. The software is integrated into ... genomic analysis solution that leverages proven open-source algorithms ... sequencing efforts. Garry Nolan,s laboratory ...
(Date:9/30/2015)... Sept. 30, 2015  With nearly 300,000 Americans living ... new SCIs estimated to reach 12,500 annually, the role ... Resource Services for Independent Living (SCRS-IL) is increasingly ... California opening doors to independence for ... and services, notably assistive technology services and education. ...
Breaking Biology News(10 mins):
... programmed from birth to develop the ability to determine ... the University of Chicago shows. The research sheds ... basic human behaviors, according to Brian Prendergast, associate professor ... of a paper published April 27 in the journal ...
... tiny shuttles to deliver genes to cells and drugs ... possible in the past. But as the scientists ... arisen about their potential toxicity. Studies of both ... the ability of scientists to quantify the interaction between ...
... the enemy of the good, but in the nanoscale world, perfection ... workaday world, engineers and scientists go to great lengths to make ... on a light switch or turn the key on the car, ... start every time, with only rare exceptions. They have done so ...
Cached Biology News:
RayBio Human Chemokine Antibody Array 1.1 (8) with Accessory, detects 38 chemokine factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
... Freezing-point Osmometer for 30 L samples, featuring 24-position turntable. Provides up to 30 minutes of ... software for statistical analysis and record keeping. RS-232 port. ... ... ...
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Gamma Globulin (BGG) through lysine by amide bonds....
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
Biology Products: